Differential regulation of C3 gene expression in human astroglioma cells by interferon-γ and interleukin-1β
- 8 September 1995
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 197 (2) , 121-124
- https://doi.org/10.1016/0304-3940(95)11923-k
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Complement Biosynthesis in the Central Nervous SystemCritical Reviews in Oral Biology & Medicine, 1995
- Transforming growth factor-beta 1 inhibits inflammatory cytokine-induced C3 gene expression in astrocytes.The Journal of Immunology, 1994
- Interleukin‐1 and tumor necrosis factor‐mediated regulation of C3 gene expression in human astroglioma cellsGlia, 1993
- Production and interferon-γ-mediated regulation of complement component C2 and factors B and D by the astroglioma cell line U105-MGBiochemical Journal, 1992
- Interferon-gamma regulation of C3 gene expression in human astroglioma cellsJournal of Neuroimmunology, 1992
- Interferon‐mediated transcriptional and post‐transcriptional modulation of complement gene expression in human monocytesEuropean Journal of Biochemistry, 1990
- Modulation by interferons of the expression of monocyte complement genesBiochemical Journal, 1990
- Interferon‐γ activates multiple pathways to regulate the expression of the genes for major histocompatibility class II I‐Aβ, tumor necrosis factor and complement component C3 in mouse macrophagesEuropean Journal of Immunology, 1989
- Modulation of monocyte complement synthesis by interferonsBiochemical Journal, 1987
- Heterogeneity of Genotypic and Phenotypic Characteristics of Fifteen Permanent Cell Lines Derived from Human GliomasJournal of Neuropathology and Experimental Neurology, 1981